Cited by 229RNA and protein synthesis mechanismsRNA modifications and cancerDNA and Nucleic Acid Chemistry

Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA

Open access
Woodcock, J., Moazed, D., Cannon, M., Davies, J., Noller, H.F.·1991·The EMBO Journal

Abstract

We have studied the interactions of the antibiotics apramycin, kasugamycin, myomycin, neamine and pactamycin with 16S rRNA by chemical probing of drug-ribosome complexes. Kasugamycin and pactamycin, which are believed to affect translational initiation, protect bases in common with P-site-bound tRNA. While kasugamycin protects A794 and G926, and causes enhanced reactivity of C795, pactamycin protects G693 and C795. All four of these bases were previously shown to be protected by P-site tRNA or by edeine, another P-site inhibitor. Apramycin and neamine, which both induce miscoding and inhibit translocation, protect A1408, G1419 and G1494, as was also found earlier for neomycin, gentamicin, kanamycin and paromomycin. A1408 and G1494 were previously shown to be protected by A-site tRNA. Surprisingly, myomycin fails to give strong protection of any bases in 16S rRNA, in spite of having an apparently identical target site and mode of action to streptomycin, which protects several bases in the 915 region. Instead, myomycin gives only weak protection of A1408. These results suggest that the binding site(s) of streptomycin and myomycin have yet to be identified.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1991.tb07863.x

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 5

  1. Cundliffe,E. (1981) In Gale,E.F., Cundliffe,E.* Reynolds,P.E.. Richmond,M.H. and Waring,M.J. (eds), The Molecular Basis of Antibiotic Action. John Wiley and Sons, New York, pp. 402 -457.
  2. Cundliffe,E. (1990) In Hill,W.E., Dahlberg,A.E., Garrett,R.A., Moore,P.B., Schlessinger,D. and Warner,J.R. (eds), The Ribosome, Structure, Function & Evolution. American Society for Microbiology, Washington, DC, pp. 479-490.
  3. De Stasio,E.A., Goringer,H.U., Tapprich,W.E. and Dahlberg,A.E. (1988) In Tuite,M.F., Picard,M. and Bolotin-Fukuhara,M. (eds), Genetics of Translation: New Approaches. Springer-Verlag, pp. 17-42.
  4. Moazed,D. and Noller,H.F. (1991) Proc. Natl. Acad. Sci. USA, in press.
  5. Noller,H.F., Moazed,D., Stem,S., Powers,T., Allen,P.N., Robertson,J.M., Weiser,B. and Triman,K. (1990) In Hill,W.E., Dahlberg,A.E., Garrett,R.A., Moore,P.B., Schlessinger,D. and Warner,J.R. (eds), The Ribosome. Structure, Function & Evolution. American Society for Microbiology, Washington, DC, pp. 73-92.

Cited by

Sorted by citations

Authors
Woodcock, J., Moazed, D., Cannon, M., Davies, J., & Noller, H. F.
Affiliations
King's College London (GB)
Venue
The EMBO Journal
Published
1991-10-01
Volume
10
Issue
10
Pages
3099-3103
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W196443510
Cited by
229
References
0
Citations by year
2025: 1 · 2024: 7 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 8 · 2013: 6 · 2012: 6
FWCI
2.12
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Wellcome Trust
  • Nuffield Foundation
  • National Institutes of Health (GM-17129)
  • National Cancer Institute
  • National Institute of General Medical Sciences (GM-17129)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
Keywords
antibiotics, 16S rRNA, A-site, P site, translation initiation, kasugamycin, pactamycin, apramycin, neamine, streptomycin, A-site tRNA, P-site tRNA, chemical probing
MeSH terms
Aminoglycosides, Anti-Bacterial Agents, Autoradiography, Escherichia coli, Nebramycin, Neomycin, Nucleic Acid Conformation, Nucleic Acid Hybridization, RNA, Ribosomal, 16S

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review